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INTRODUCTION
Mediterranean spotted fever (MSF) is caused by
Rickettsia conorii conorii transmitted by the brown
dog tick Rhipicephalus sanguineus. It is endemic in
the Mediterranean area, where most of the cases
are encountered during the summer, when the
tick vectors are highly active [1]. In Morocco, MSF
has been the sole human tick-borne rickettsiosis
known by clinicians, and cases that are clinically
recognized are rarely documented [2]. Our aim is
to describe the clinical and epidemiological
characteristics of conﬁrmed cases of MSF in
Casablanca and in the surrounding regions of
Morocco.
PATIENTS AND METHODS
Between May and December 2007, we included in this study
patients seen at the Infectious Diseases Division of the Ibn
Rochd Casablanca Teaching Hospital and at the Pasteur
Institute of Morocco, with unexplained fever and ⁄ or eruptive
fever and ⁄or elevated serum levels of liver transaminases.
Clinical and epidemiological data, laboratory results, treat-
ments and outcomes of the patients were collected on a
standardized questionnaire. For each patient, the study
involved the gathering of an acute-phase serum sample within
2 weeks of the onset of symptoms and, if possible, a conva-
lescent-phase serum sample (i.e. one collected 1–2 weeks
later). Punch biopsies were performed on skin lesions, espe-
cially on the eschar. Sera were tested in a multiple-antigen
immunoﬂuorescence assay using nine SFG rickettsial antigens,
including R. conorii conorii strain 7, Rickettsia africae, Rickettsia
sibirica mongolitimonae, Rickettsia aeschlimannii, Rickettsia massi-
liae, Rickettsia helvetica, Rickettsia slovaca, R. conorii israelensis,
and Rickettsia felis, and a typhus group antigen, Rickettsia typhi.
The rationale for the antigen screening panel was supported by
the presence of rickettsial species or subspecies in the Med-
iterranean area. When cross-reactions were noted between
several rickettsial antigens, the standard procedure of the
Unite´ des Rickettsies was followed, including Western blotting
and cross-adsorption studies to complement the immunoﬂu-
orescence assay [3,4]. Also, DNA was extracted from skin
biopsy specimens using the QIAamp DNA Mini Kit (Qiagen,
Hilden, Germany). Standard PCR was performed with primers
suitable for hybridization within the conserved region of genes
coding for outer membrane protein A (ompA) and citrate
synthase (gltA) [3].
RESULTS
Forty-ﬁve patients were included in the study,
65% were men, and 68% of patients were diag-
nosed between August and September. The aver-
age age of the 42 adult patients was 47.3 years,
and that of the three children was 5 years. Among
the 45 included patients, 77% had been exposed
to dogs, 35% had reported tick bites, and 75%
had inoculation eschars (25% of them presented
with several inoculation eschars); 70% of the
patients were treated with doxycycline, 16% with
ﬂuoroquinolones, 10% (n = 4) with thiampheni-
col, and 2% (n = 1) with josamycine. Three
patients were hospitalized in intensive-care units,
and one of them died.
Among the 45 patients, 28 had signiﬁcant
antibody titres against spotted fever group (SFG)
rickettsiae with cross-reactions between several
rickettsial antigens. Western blotting and cross-
adsorption studies were performed on patients
with no eschar biopsies or with negative results
on skin biopsy specimens. Antibodies speciﬁcally
directed against R. conorii conorii were found for
nine patients. Twelve (41%) of 29 obtained skin
biopsy specimens tested positive by PCR. All
sequences obtained from positive PCR products
shared 99.5% homology with the corresponding
sequence for R. conorii conorii strain Malish
ompA (GenBank accession number AE008674)
and 99.8% homology with the corresponding
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sequence for R. conorii conorii strain Malish gltA
(GenBank accession number AE008677). Overall,
21 patients of 32 who had antibodies directed
against SFG rickettsial antigens and ⁄ or positive
skin biopsy specimens were deﬁnitely conﬁrmed
as having MSF due to R. conorii conorii. The
clinical data of these conﬁrmed cases are pre-
sented in Table 1.
DISCUSSION
This study is the largest series of MSF diagnosed
in Morocco with the reference methods allowing
deﬁnitive conﬁrmation of the rickettsia involved.
MSF seems to be the most common rickettsial
infection in the country, at least during the
summer and in the Casablanca area. It is of
interest that 14% of the patients with conﬁrmed
MSF presented with multiple eschars. This is
thought to be unusual in MSF, for which the
typical inoculation eschar at the tick bite site is
usually unique, because the brown dog tick is
known to have a low propensity to bite people.
On the other hand, other SFG tick-borne rickett-
sioses are characterized by multiple eschars
linked with aggressive vectors that readily bite
people. However, particular climatic circum-
stances, including higher temperatures, may have
led to an increased proclivity of ticks to bite
humans [5]. None of the emerging pathogens that
have been detected in ticks in Morocco were
diagnosed in our patients, such as R. massiliae,
R. slovaca, Rickettsia raoultii, R. aeschlimannii, Rick-
ettsia monacensis and R. helvetica [6]. Clinicians
have to be aware of the potential severity of the
disease as demonstrated here, with a case–fatality
rate of 5%. However, more studies are needed,
including elsewhere in Morocco and at different
periods of the year.
REFERENCES
1. Parola P, Paddock C, Raoult D. Tick-borne rickettsioses
around the world: emerging diseases challenging old con-
cepts. Clin Microbiol Rev 2005; 18: 719–756.
2. Charra B, Berrada J, Hachimi A, Judate I, Nejmi H, Mot-
aouakkil S. A fatal case of Mediterranean spotted fever.Med
Mal Infect 2005; 35: 374–375.
3. Mouffok N, Benabdellah A, Richet H et al. Reemergence of
rickettsiosis in Oran, Algeria. Ann NY Acad Sci 2006; 1078:
180–184.
4. Jensenius M, Fournier PE, Vene S, Ringertz SH, Myrvang B,
Raoult D. Comparison of immunoﬂuorescence, Western
blotting, and cross-adsorption assays for diagnosis of
African tick bite fever. Clin Diagn Lab Immunol 2004; 11: 786–
788.
5. Parola P, Socolovschi C, Jeanjean L, Bitam I, Fournier PE,
Sotto A, Labauge P, Raoult D. Warmer weather linked to
tick attack and emergence of severe rickettsioses. PLoS Negl
Trop Dis. 2008; 2 (11): e338.
6. Sarih M, Socolovschi C, Boudebouch N, Hassar M, Raoult
D, Parola P. Spotted fever group rickettsiae in ticks, Mor-
occo. Emerg Infect Dis 2008; 14: 1067–1073.
Table 1. Clinical signs of 21 patients conﬁrmed to have
Mediterranean spotted fever caused by Rickettsia conorii
conorri in Casablanca, Morocco, 2007
Findings n (%)
High fever 21 ⁄ 21 (100)
Myalgia 20 ⁄ 21 (95)
Arthralgia 20 ⁄ 21 (95)
Cutaneous rasha 21 ⁄ 21 (100)
Headache 21 ⁄ 21 (100)
Conjunctivitis 1 ⁄ 21 (5)
Single eschar 15 ⁄ 21 (75)
Multiple eschars 5 ⁄ 21 (14)
Meningism 1 ⁄ 21 (5)
Liver transaminases >50 UI ⁄L 9 ⁄ 15 (60)
Platelets <15010 exp 9 = 1 000 000 000 ⁄L 8 ⁄ 16 (50)
Lymphadenodenopathy 3 ⁄ 20 (15)
Death 1 ⁄ 21 (5)
aIncluding 17 patients with maculopapular rash and four patients with purpuric
rash.
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